Cargando…
Use of insulin degludec/aspart after resolution of euglycemic diabetic ketoacidosis associated with dapagliflozin in a female patient with newly diagnosed maturity onset diabetes of the young type 3
INTRODUCTION: Maturity-onset diabetes of the young (MODY) is a monogenic disorder characterized by beta cell dysfunction. MODY presents generally at a young onset, and usually does not prone to ketosis. MODY should be distinguished from type 1(T1D) or type 2 diabetes(T2D), because the treatment moda...
Autores principales: | Ayhan, Ihsan, Topaloğlu, Ömercan, Tekin, Sakin, Bayraktaroğlu, Taner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653156/ http://dx.doi.org/10.1210/jcemcr/luac014.028 |
Ejemplares similares
-
Successful use of liraglutide in a female patient with type 1 Gaucher disease, type 2 diabetes mellitus and obesity
por: Topaloğlu, Ömercan, et al.
Publicado: (2023) -
Injection site reaction induced by liraglutide use in a female patient with obesity
por: Ayhan, Ihsan, et al.
Publicado: (2023) -
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019) -
Diabetic Ketoacidosis in an Euglycemic Patient
por: Mumtaz, Hassan, et al.
Publicado: (2020) -
Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis
por: Wang, Qianwen, et al.
Publicado: (2022)